✦ LIBER ✦

Docetaxel and carboplatin combination as second-line treatment in metastatic non-small-cell lung cancer(NSCLC)

✍ Scribed by J.W.G. Van Putten; F.M. Wachters; H.J.M. Groen

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Docetaxel and carboplatin as second-line

✍ Laack, Eckart; Dierlamm, Thorsten; Knuffmann, Claudia; Popp, Johann; Schmied, Bi 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 92 KB

Combination of docetaxel and carboplatin

✍ Bando, H; Miyata, J; Sano, T; Sumitomo, M; Nagano, T 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 108 KB

Docetaxel and mitomycin as second-line t

✍ J. Feliu; G. Martín; J. Castro; A. Sundlov; A. Rodriguez-Jaráiz; E. Casado; M. L 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 209 KB

Phase II study of docetaxel (DOC) and ca

✍ van Putten, J.W.G; Slebos, D.J; Groen, H.J.M 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 113 KB

P-17 Docetaxel and carboplatin as a seco

✍ Hatabay, Nilgün; Ece, Ferah 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 171 KB

Weekly docetaxel vs. docetaxel-based com

✍ Gebbia, Vittorio; Gridelli, Cesare; Verusio, Claudio; Frontini, Luciano; Aitini, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 334 KB